<p>IMMUNOTECH-B (06978.HK) announced its interim results for the six months ending in June, recording other income of RMB 13.04 million, an increase of 99.8% year-on-year. The loss widened from RMB 92.52 million in the same period last year to RMB 129 million, with a loss per share of 25 cents. No dividend is declared</p>

06978

<p>IMMUNOTECH-B announced its interim results for the six months ending in June, recording other income of RMB 13.04 million, an increase of 99.8% year-on-year. The loss widened from RMB 92.52 million in the same period last year to RMB 129 million, with a loss per share of 25 cents. No dividend is declared</p>

《業績》永泰生物中期虧損擴至 1.29 億人民幣